Search
Search Results
-
Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study
IntroductionThe ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) European Union (EU) is part of an overarching...
-
Unmet Needs in the Acute Treatment of Migraine
Migraine represents the most common neurologic disorder, ranking second among the world’s causes of disability [expressed as years lived with...
-
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Rimegepant [Nurtec ® ODT (USA); Vydura ® (EU)] is a calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of...
-
Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)
IntroductionMigraine, characterized by recurrent headaches and often accompanied by other symptoms like nausea, vomiting, and sensitivity to light...
-
Advances in the Acute and Preventive Treatment of Pediatric Migraine
Purpose of ReviewHeadaches are common in children and adolescents. Treatments for debilitating migraine are often not FDA approved or lack evidence...
-
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review
IntroductionThirty years ago, the first migraine-specific drugs (triptans) appeared. Today two new categories (gepants and ditans) are marketed for...
-
Acute treatment of migraine: quantifying the unmet need through real-world data in Italy
ObjectiveThis study is describing subjects with migraine interrupting or not receiving triptans for acute treatment and providing a national-level...
-
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review
IntroductionNonsteroidal anti-inflammatory drugs (NSAIDs) have been the first-line choice for the acute treatment of migraine attacks for decades;...
-
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse
BackgroundMigraine is a disabling neurologic disease that can fluctuate over time in severity, frequency, and acute medication use. Harris Poll...
-
Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
BackgroundKnowledge of patient outcomes and treatment effectiveness associated with acute migraine treatments in Japan is lacking.
Objective ...
-
Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE
IntroductionAlthough acute and preventive treatments for migraine are commonly given in combination, data on the real-world effectiveness of...
-
Preventing the Progression of Episodic Migraine to Chronic Migraine with Acute Treatment Optimization
Purpose of ReviewTo evaluate the evidence regarding acute migraine treatment optimization to prevent the progression of episodic migraine to chronic...
-
Triptans in the Acute Migraine Management of Children and Adolescents: An Update
Purpose of ReviewTo summarize recent findings regarding triptan use in the acute treatment of pediatric migraine.
Recent FindingsPrevalence of...
-
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
IntroductionMedications for preventive treatment of migraine reduce migraine frequency, usually measured by a reduction in monthly migraine days...
-
Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study
IntroductionUsing data from the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE study in Japan (OVERCOME [Japan]), we...
-
Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
BackgroundIndividuals using onabotulinumtoxinA as a preventive migraine treatment often use acute treatments for breakthrough attacks. Data on...
-
The Efficacy of Different Triptans for the Treatment of Acute Headache in Pediatric Migraine: A Systematic Review
BackgroundSerotonin receptors 5-HT1B and 5-HT1D in the cerebral arteries are activated by the 5-hydroxytryptophan agonists (triptans) to relieve the...
-
Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway
BackgroundNew acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes...
-
Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis
BackgroundIntranasal agents may be ideal for the treatment of migraine patients. Many new acute intranasal-specific therapies have been developed,...
-
Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China
IntroductionMigraine is a common disabling primary headache disorder characterized by attacks of severe pain, sometimes accompanied by symptoms...
